by Media Coverage | Jul 1, 2018 | Blog
Month: July 2018 FollowFollowFollow Headquartered in Richmond, California with an ISO 13485 and CLIA certified facility, DiaCarta develops, manufactures, and markets cancer research and IVD products and performs molecular testing ‘liquid biopsy’ services for precision...
by DiaCarta Inc. | Jul 2, 2018 | Blog
Month: July 2018 FollowFollowFollow 1. The challenges that our clients faced Acute myeloid leukemia (AML) is an aggressive hematopoietic neoplasm characterized by an accumulation of myeloid cells in the bone marrow because of impaired differentiation and...
by Media Coverage | Jul 2, 2018 | Blog
Month: July 2018 FollowFollowFollow At a pathology lab, a researcher is working on a patient’s blood sample to extract cell-free DNA to find the potential diagnostic biomarker for cancers. Using the current DNA sequencing techniques such as next-generation sequencing...
by Media Coverage | Aug 1, 2018 | Blog
Media Coverage FollowFollowFollow Molecular Diagnostics has evolved over the years and the numerous benefits it has to offer has earned people’s attention irrespective of the expensive procedures it included. Quicker turnaround times, improved sensitivities, increased...
by Wei Liu, Ph.D. | Aug 7, 2018 | Blog
Month: August 2018 FollowFollowFollow When mutated, oncogenes can convert normal cells to cancer cells. BRAF is one of the oncogenes that controls transduction of chemical signal from outside the cells to nucleus. As a member of the RAS/MAPK pathway, the BRAF gene...
by Wei Liu, Ph.D. | Sep 11, 2018 | Blog
Month: September 2018 FollowFollowFollow Genome-wide next-generation of sequencing (NGS), such as whole genome sequencing (WGS) and whole exome sequencing (WES) has been used for germline and somatic mutation studies. However, due to the high cost and turnaround time,...
Recent Comments